Vulvar Cancer
- PMID: 33620867
- Bookshelf ID: NBK567798
Vulvar Cancer
Excerpt
According to the Surveillance, Epidemiology, and End Results (SEER) Program, vulvar cancer represents 0.3% of all new cancer cases annually at a rate of 2.6 per 100,000 women per year in the United States. Diagnosis is usually made in the sixth through eighth decades of life and is commonly identified early in the disease. Squamous cell carcinoma (SCC) accounts for most vulvar cancers, while basal cell carcinoma (BCC), extramammary Paget disease, and vulvar melanoma comprise the less common subtypes. Surgery remains the mainstay of vulvar cancer treatment, with medical and radiation oncology playing an increasingly important role in preventing recurrence and improving outcomes.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
- Continuing Education Activity
- Introduction
- Etiology
- Epidemiology
- Pathophysiology
- Histopathology
- History and Physical
- Evaluation
- Treatment / Management
- Differential Diagnosis
- Surgical Oncology
- Radiation Oncology
- Medical Oncology
- Staging
- Prognosis
- Complications
- Postoperative and Rehabilitation Care
- Deterrence and Patient Education
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
References
-
- Khanna N, Rauh LA, Lachiewicz MP, Horowitz IR. Margins for cervical and vulvar cancer. J Surg Oncol. 2016 Mar;113(3):304-9. - PubMed
-
- Canavan TP, Cohen D. Vulvar cancer. Am Fam Physician. 2002 Oct 01;66(7):1269-74. - PubMed
-
- Boer FL, Ten Eikelder MLG, Kapiteijn EH, Creutzberg CL, Galaal K, van Poelgeest MIE. Vulvar malignant melanoma: Pathogenesis, clinical behaviour and management: Review of the literature. Cancer Treat Rev. 2019 Feb;73:91-103. - PubMed
-
- Weinberg D, Gomez-Martinez RA. Vulvar Cancer. Obstet Gynecol Clin North Am. 2019 Mar;46(1):125-135. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials